REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,685,528 | +199.9% | 205,402 | +189.8% | 0.00% | – |
| Q2 2023 | $1,895,666 | +44.6% | 70,866 | +17.1% | 0.00% | – |
| Q1 2023 | $1,310,820 | +106.9% | 60,518 | +127.6% | 0.00% | – |
| Q4 2022 | $633,445 | +19.5% | 26,593 | -1.2% | 0.00% | – |
| Q3 2022 | $530,000 | +17.8% | 26,922 | +16.6% | 0.00% | – |
| Q2 2022 | $450,000 | -23.2% | 23,085 | +0.6% | 0.00% | – |
| Q1 2022 | $586,000 | +2.3% | 22,939 | +0.9% | 0.00% | – |
| Q4 2021 | $573,000 | +5.5% | 22,733 | +15.1% | 0.00% | – |
| Q3 2021 | $543,000 | -27.6% | 19,749 | -16.4% | 0.00% | – |
| Q2 2021 | $750,000 | +80.7% | 23,622 | +160.9% | 0.00% | – |
| Q1 2021 | $415,000 | -38.9% | 9,054 | -47.2% | 0.00% | – |
| Q4 2020 | $679,000 | +30.3% | 17,153 | +4.1% | 0.00% | – |
| Q2 2020 | $521,000 | – | 16,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |